A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity

Weggen, Sascha, Eriksen, Jason L., Das, Pritam, Sagi, Sarah A., Wang, Rong, Pietrzik, Claus U., Findlay, Kirk A., Smith, Tawnya E. +6 more·2001·Nature

DOI 10.1038/35102591

Cited by (1,001)

Items 101–200 of 1,001

Reduced incidence of AD with NSAID but not H2receptor antagonists
Peter P. Zandi, James Christopher Anthony, Kathleen M. Hayden, Kala M. Mehta, Lawrence S. Mayer, John C.S. Breitner · 2002 · Neurology
γ-Secretase in Alzheimer’s disease
Ji‐Yeun Hur · 2022 · Experimental & Molecular Medicine
Nonsteroidal Anti-Inflammatory Drugs Can Lower Amyloidogenic Aß <sub>42</sub> by Inhibiting Rho
Zhou, Yan, Su, Yuan, Li, Baolin, Liu, Feng, Ryder, John W., Wu, Xin, Gonzalez-DeWhitt, Patricia A., Gelfanova, Valentina, Hale, John E., May, Patrick C. et al. · 2003 · Science
Depression and Alzheimer's disease: neurobiological links and common pharmacological targets.
F. Caraci, A. Copani, F. Nicoletti, F. Drago · 2010 · European Journal of Pharmacology
Update on Bispectral Index monitoring
Jay W. Johansen · 2006 · Best practice & research. Clinical anaesthesiology
Role of complement in neurodegeneration and neuroinflammation
Domenico Marco Bonifati, Uday Kishore · 2006 · Molecular Immunology
Targeting soluble Aβ peptide with Tramiprosate for the treatment of brain amyloidosis
Francine Gervais, Julie Paquette, Céline Morissette, Pascale Krzywkowski, Mathilde W. N. Yu, Mounia Azzi, Diane Lacombe, Xianqi Kong, Ahmed M. Aman, Julie Laurin et al. · 2006 · Neurobiology of Aging
The Therapeutic Potential of Metformin in Neurodegenerative Diseases
Carola Rotermund, Gerrit Machetanz, Julia Catherine Fitzgerald · 2018 · Frontiers in Endocrinology
Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial
Gordon Keith Wilcock, Sandra E. Black, Suzanne B. Hendrix, Kenton H. Zavitz, Edward A. Swabb, Mark A Laughlin · 2008 · The Lancet Neurology
GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Aβ42
Lisa Marie Munter, Philipp Voigt, Anja Harmeier, Daniela Kaden, Kay Eberhard Gottschalk, Christoph Weise, Rüdiger Pipkorn, Michael K. E. Schaefer, Dieter Langosch, Gerd Multhaup · 2007 · The EMBO Journal
Advances in developing novel therapeutic strategies for Alzheimer’s disease
Jiqing Cao, Jianwei Hou, Jing Ping, Dongming Cai · 2018 · Molecular Neurodegeneration
Diverse compounds mimic Alzheimer disease–causing mutations by augmenting Aβ42 production
Thomas L. Kukar, Michael Paul Murphy, Jason L. Eriksen, Sarah A. Sagi, Sascha Weggen, Tawnya E. Smith, Thomas B. Ladd, Murad Ali Khan, Rajashaker Kache, J. David Beard et al. · 2005 · Nature Medicine
Substrate-targeting γ-secretase modulators
Thomas L. Kukar, Thomas B. Ladd, Maralyssa A. Bann, Patrick C. Fraering, Rajeshwar Narlawar, Ghulam M. Maharvi, Brent Healy, Robert Chapman, Alfred T. Welzel, Robert W. Price et al. · 2008 · Nature
Evidence That Nonsteroidal Anti-inflammatory Drugs Decrease Amyloid β42 Production by Direct Modulation of γ-Secretase Activity
Sascha Weggen, Jason L. Eriksen, Sarah A. Sagi, Claus U. Pietrzik, Victor V. Ozols, Abdul H. Fauq, Todd Eliot Golde, Edward H. Koo · 2003 · Journal of Biological Chemistry
Cyclohexylcarbamic Acid 3‘- or 4‘-Substituted Biphenyl-3-yl Esters as Fatty Acid Amide Hydrolase Inhibitors: Synthesis, Quantitative Structure−Activity Relationships, and Molecular Modeling Studies
Marco Mor, Silvia Rivara, Alessio Lodola, Pier Vincenzo Plazzi, Giorgio Tarzia, Andrea Duranti, Andrea Tontini, Giovanni Piersanti, Satish Kathuria, Daniele Piomelli · 2004 · Journal of Medicinal Chemistry
A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease
Eric H. Karran, John Hardy · 2014 · Annals of Neurology
Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy
Jürgen Götz, Johannes Rolf Streffer, Della C. David, A Schild, Frédéric J. Hoerndli, Luis Pennanen, Pascal Kurosinski, F Chen · 2004 · Molecular Psychiatry
γ-Secretase inhibitors and modulators
Todd Eliot Golde, Edward H. Koo, Kevin M. Felsenstein, Barbara A. Osborne, Lucio Miele · 2013 · Biochimica et Biophysica Acta (BBA) - Biomembranes
Highly conserved and disease‐specific patterns of carboxyterminally truncated Aβ peptides 1–37/38/39 in addition to 1–40/42 in Alzheimer's disease and in patients with chronic neuroinflammation
Jens Wiltfang, Hermann Esselmann, Mirko Bibl, Smirnov Av, Markus Otto, S. Paul, Bernhard Schmidt, Hans‐Wolfgang Klafki, Manuel Maler, Thomas Dyrks et al. · 2002 · Journal of Neurochemistry
Axon growth inhibition by RhoA/ROCK in the central nervous system
Yuki Fujita, Toshihide Yamashita · 2014 · Frontiers in Neuroscience
The significance of neuroinflammation in understanding Alzheimer’s disease
Piet Eikelenboom, Robert Veerhuis, Wiep Scheper, Annemieke J.M. Rozemüller, Willem A. van Gool, Jeroen J.M. Hoozemans · 2006 · Journal of Neural Transmission
Microglia and neuroprotection: From in vitro studies to therapeutic applications
Elisabetta Polazzi, Barbara Monti · 2010 · Progress in Neurobiology
Therapeutic strategies for human amyloid diseases
James C. Sacchettini, Jeffery W. Kelly · 2002 · Nature Reviews Drug Discovery
Daily and Seasonal Variation in Response to Stress in Captive Starlings (Sturnus vulgaris): Corticosterone
L. Michael Romero, Luke Remage‐Healey · 2000 · General and Comparative Endocrinology
Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy
Elina Zotova, James A. R. Nicoll, Raj N. Kalaria, Clive Holmes, Delphine Boche · 2010 · Alzheimer s Research & Therapy
Age but Not Diagnosis Is the Main Predictor of Plasma Amyloid β-Protein Levels
Hiroaki Fukumoto, Marsha K. Tennis, Joseph J. Locascio, Bradley T. Hyman, John H. Growdon, Michael C. Irizarry · 2003 · Archives of Neurology
Endoplasmic reticulum stress response is involved in nonsteroidal anti-inflammatory drug-induced apoptosis
Shinji Tsutsumi, Tomomi Gotoh, Wataru Tomisato, S Mima, Tatsuya Hoshino, H-J Hwang, Hitomi Takenaka, Tomofusa Tsuchiya, Masataka Mori, T. Mizushima · 2004 · Cell Death and Differentiation
Modulation of γ-Secretase Reduces β-Amyloid Deposition in a Transgenic Mouse Model of Alzheimer's Disease
Maria Z. Kounnas, Anne M. Danks, Soan Cheng, Curtis M. Tyree, Elizabeth S. Ackerman, Xulun Zhang, Kwangwook Ahn, Phuong Anh H. Nguyen, Dan Comer, Long Mao et al. · 2010 · Neuron
Antioxidants as treatment for neurodegenerative disorders
Bernd Moosmann, Christian Behl · 2002 · Expert Opinion on Investigational Drugs
DOGS: Reaction-Driven de novo Design of Bioactive Compounds
Hartenfeller, Markus, Zettl, Heiko, Walter, Miriam, Rupp, Matthias, Reisen, Felix, Proschak, Ewgenij, Weggen, Sascha, Stark, Holger, Schneider, Gisbert · 2012 · PLoS Computational Biology
Alzheimer’s-Causing Mutations Shift Aβ Length by Destabilizing γ-Secretase-Aβn Interactions
Szaruga, Maria, Munteanu, Bogdan, Lismont, Sam, Veugelen, Sarah, Horré, Katrien, Mercken, Marc, Saido, Takaomi C., Ryan, Natalie S., De Vos, Tatjana, Savvides, Savvas N. et al. · 2017 · Cell
Amyloid β-Protein Monomer Folding: Free-Energy Surfaces Reveal Alloform-Specific Differences
Mingfeng Yang, David B. Teplow · 2008 · Journal of Molecular Biology
ROCK inhibition in models of neurodegeneration and its potential for clinical translation
Koch, Jan Christoph, Tatenhorst, Lars, Roser, Anna-Elisa, Saal, Kim-Ann, Tönges, Lars, Lingor, Paul · 2018 · Pharmacology & Therapeutics
Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761
Julie V Smith, Yuan Luo · 2003 · Journal of Alzheimer s Disease
Are NSAIDs useful to treat Alzheimer’s disease or mild cognitive impairment?
Bruno Pietro Imbimbo · 2010 · Frontiers in Aging Neuroscience
NLRP3 Inflammasome Inhibitor Ameliorates Amyloid Pathology in a Mouse Model of Alzheimer’s Disease
Jun Yin, Fanpeng Zhao, Jeremy E. Chojnacki, Jacob Fulp, William L. Klein, Shijun Zhang, Xiongwei Zhu · 2017 · Molecular Neurobiology
Persistent Amyloidosis following Suppression of Aβ Production in a Transgenic Model of Alzheimer Disease
Jankowsky, Joanna L, Slunt, Hilda H, Gonzales, Victoria, Savonenko, Alena V, Wen, Jason C, Jenkins, Nancy A, Copeland, Neal G, Younkin, Linda H, Lester, Henry A, Younkin, Steven G et al. · 2005 · PLoS Medicine
Activation of β2-adrenergic receptor stimulates γ-secretase activity and accelerates amyloid plaque formation
Yanxiang Ni, Xiaohui Zhao, Guobin Bao, Lin Zou, Lin Teng, Zhu Wang, Min Song, Jiaxiang Xiong, Yun Bai, Gang Pei · 2006 · Nature Medicine
Astrocytes: Conductors of the Alzheimer disease neuroinflammatory symphony
Rodrigo Medeiros, Frank M. LaFerla · 2012 · Experimental Neurology
Novel Research Horizons for Presenilins and γ-Secretases in Cell Biology and Disease
Bart De Strooper, Wim G. Annaert · 2010 · Annual Review of Cell and Developmental Biology
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Alberto Ardura-Fabregat, Erik Boddeke, Antonio Boza‐Serrano, Simone Brioschi, Sergio Castro‐Gomez, Kelly Ceyzériat, Cira Dansokho, Tobias Dierkes, Géraldine Gelders, Michael Thomas Heneka et al. · 2017 · CNS Drugs
The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease.
Brandy L. Wilkinson, Gary E. Landreth · 2006 · Journal of Neuroinflammation
Ligand-Controlled Regioselective Hydrocarboxylation of Styrenes with CO2 by Combining Visible Light and Nickel Catalysis
Qingyuan Meng, Shun Wang, Gregory S. Huff, Burkhard König · 2018 · Journal of the American Chemical Society
Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors
Haythum Osama Tayeb, Hyun Duk Yang, Bruce Heimburger Price, Frank I. Tarazi · 2011 · Pharmacology & Therapeutics
Treatment for mild cognitive impairment: systematic review
Claudia Cooper, Ryan Li, Constantine George Lyketsos, Gill Livingston · 2013 · The British Journal of Psychiatry
Deletion of the Prostaglandin E2EP2 Receptor Reduces Oxidative Damage and Amyloid Burden in a Model of Alzheimer's Disease
Xibin Liang, Qian Wang, Tracey A. Hand, Liejun Wu, RICHARD M. BREYER, Thomas Jude Montine, Katrin I. Andreasson · 2005 · Journal of Neuroscience
Mutations that Reduce Aggregation of the Alzheimer's Aβ42 Peptide: an Unbiased Search for the Sequence Determinants of Aβ Amyloidogenesis
Christine Wurth, Nathalie K. Guimard, Michael H. Hecht · 2002 · Journal of Molecular Biology
Effects of cannabidiol interactions with Wnt/&beta;-catenin pathway and PPAR&gamma; on oxidative stress and neuroinflammation in Alzheimer's disease
Vallée, Alexandre, Lecarpentier, Yves, Guillevin, Rémy, Vallée, Jean-Noël · 2017 · Acta Biochimica et Biophysica Sinica
Inflammation, anti-inflammatory agents and Alzheimer disease: The last 12 years
Patrick L. McGeer, Joseph Rogers, Edith G. McGeer · 2006 · Journal of Alzheimer s Disease
Prevention of Alzheimer's disease: Omega-3 fatty acid and phenolic anti-oxidant interventions
Greg M. Cole, Giselle P. Lim, Fusheng Yang, Bruce Teter, Aynun Nahar Begum, Qiu‐Lan Ma, Marni E. Harris‐White, Sally Ann Frautschy · 2005 · Neurobiology of Aging
Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer’s disease
Ling, Yan, Morgan, Kevin, Kalsheker, Noor · 2003 · The International Journal of Biochemistry & Cell Biology
Non‐steroidal anti‐inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action
Gasparini, Laura, Ongini, Ennio, Wenk, Gary · 2004 · Journal of Neurochemistry
Alzheimer's disease and angiogenesis
Eleftherios I. Agorogiannis, George I Agorogiannis · 2003 · The Lancet
Risk Factors for Dementia
Chen, Jen-Hau, Lin, Kun-Pei, Chen, Yen-Ching · 2009 · Journal of the Formosan Medical Association
Interleukin-1β impairs brain derived neurotrophic factor-induced signal transduction
Tong, Liqi, Balazs, Robert, Soiampornkul, Rungtip, Thangnipon, Wipawan, Cotman, Carl W. · 2008 · Neurobiology of Aging
Current drug targets for Alzheimer's disease treatment
Debomoy K. Lahiri, Martin Rhys Farlow, Nigel H. Greig, Kumar Sambamurti · 2002 · Drug Development Research
Drug discovery in dementia: the role of rodent models
Debby Van Dam, Peter Paul De Deyn · 2006 · Nature Reviews Drug Discovery
Cyclooxygenase-2 inhibition improves amyloid-β-mediated suppression of memory and synaptic plasticity
Linda Kotilinek, Marcus A. Westerman, Qinwen Wang, Kimberly L. Panizzon, Giselle P. Lim, Ágnes Simonyi, Sylvain Lesné, Agnieszka M. Falinska, Linda H. Younkin, Steven G. Younkin et al. · 2008 · Brain
Neurotherapeutic applications of nanoparticles in Alzheimer’s disease
Sahni, Jasjeet Kaur, Doggui, Sihem, Ali, Javed, Baboota, Sanjula, Dao, Lé, Ramassamy, Charles · 2011 · Journal of Controlled Release
Mitochondrial Ca2+ Overload Underlies Aβ Oligomers Neurotoxicity Providing an Unexpected Mechanism of Neuroprotection by NSAIDs
Sara Sanz‐Blasco, Ruth Ana Valero, Ignacio Rodríguez‐Crespo, Carlos Villalobos, Lucı́a Núñez · 2008 · PLoS ONE
Cell-Autonomous Death of Cerebellar Purkinje Neurons with Autophagy in Niemann-Pick Type C Disease
Dennis C. Ko, Ljiljana Milenković, Steven Beier, Hermogenes Manuel, JoAnn Buchanan, Matthew P. Scott · 2005 · PLoS Genetics
Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease
Farfara, D., Lifshitz, V., Frenkel, D. · 2008 · Journal of Cellular and Molecular Medicine
β-Amyloid-Induced Inflammation and Cholinergic Hypofunction in the Rat Brain in Vivo: Involvement of the p38MAPK Pathway
Maria Grazia Giovannini, Carla Scali, Costanza Prosperi, Arianna Bellucci, Maria Giuliana Vannucchi, Susanna Rosi, Giancarlo Pepeu, Fiorella Casamenti · 2002 · Neurobiology of Disease
Wnt signaling in neuroprotection and stem cell differentiation
Enrique M. Toledo, Marcela Colombres, Nibaldo C. Inestrosa · 2008 · Progress in Neurobiology
Impact of Cytokines and Chemokines on Alzheimer’s Disease Neuropathological Hallmarks
Catarina Domingues, Odete A. B. da Cruz e Silva, Ana Gabriela Henriques · 2017 · Current Alzheimer Research
Raging the War Against Inflammation With Natural Products
Ali Attiq, Juriyati Jalil, Khairana Husain, Waqas Ahmad · 2018 · Frontiers in Pharmacology
Interaction of intracellular β amyloid peptide with chaperone proteins
Virginia G. Fonte, Wadim J Kapulkin, Andrew S. Taft, Amy Fluet, David Friedman, Christopher D. Link · 2002 · Proceedings of the National Academy of Sciences
Chronic nicotine treatment reduces β‐amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw)
Agneta K. Nordberg, Ewa Hellström‐Lindahl, Mandy Lee, Mary Ann Johnson, Malahat T. Mousavi, Ros Hall, Elaine King Perry, I. Bednar, JENNIFER A. COURT · 2002 · Journal of Neurochemistry
Anti-A 42- and anti-A 40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model
Yona Levites · 2005 · Journal of Clinical Investigation
Intramembrane Proteolysis by γ-Secretase
Harald Steiner, Regina Fluhrer, Christian Haass · 2008 · Journal of Biological Chemistry
The role of Wnt signaling in neuronal dysfunction in Alzheimer's Disease
Nibaldo C. Inestrosa, Enrique M. Toledo · 2008 · Molecular Neurodegeneration
NSAID use and dementia risk in the Cardiovascular Health Study*: Role of <i>APOE</i> and NSAID type
Szekely, C. A., Breitner, J.C.S., Fitzpatrick, A. L., Rea, T. D., Psaty, B. M., Kuller, L. H., Zandi, P. P. · 2008 · Neurology
The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease
Paul S. S. Aisen · 2002 · The Lancet Neurology
Nonsteroidal anti-inflammatory drugs lower Aβ42 and change presenilin 1 conformation
Alberto Lleó, Oksana Berezovska, Lauren D. Herl, Susan Raju, Amy Deng, Brian J. Bacskai, Matthew P. Frosch, Michael C. Irizarry, Bradley T. Hyman · 2004 · Nature Medicine
A presenilin dimer at the core of the γ-secretase enzyme: Insights from parallel analysis of Notch 1 and APP proteolysis
Eric H. Schroeter, Ma. Xenia G. Ilagan, Anne L. Brunkan, Silva Katusic Hecimovic, Yue‐Ming Li, Min Xu, Huw D. Lewis, Meera T. Saxena, Bart De Strooper, Archie Coonrod et al. · 2003 · Proceedings of the National Academy of Sciences
Reversal of Alzheimer’s-like pathology and behavior in human APP transgenic mice by mutation of Asp664
Galvan, Veronica, Gorostiza, Olivia F., Banwait, Surita, Ataie, Marina, Logvinova, Anna V., Sitaraman, Sandhya, Carlson, Elaine, Sagi, Sarah A., Chevallier, Nathalie, Jin, Kunlin et al. · 2006 · Proceedings of the National Academy of Sciences
Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti‐inflammatory drugs
Kirk P. Townsend, Domenico Praticò · 2005 · The FASEB Journal
Ibuprofen reduces Aβ, hyperphosphorylated tau and memory deficits in Alzheimer mice
Ann Carolyn McKee, Isabel Carreras, Lokman Hossain, Hoon Ryu, William L. Klein, Salvatore Oddo, Frank M. LaFerla, Bruce G. Jenkins, Neil W. Kowall, Alpaslan Dedeoglu · 2008 · Brain Research
γ-Secretase Inhibitors and Modulators for the Treatment of Alzheimer's Disease: Disappointments and Hopes
Bruno Pietro Imbimbo, Giuseppe A. M. Giardina · 2011 · Current Topics in Medicinal Chemistry
β-Secretase inhibition for the treatment of Alzheimer's disease – promise and challenge
Martin Citron · 2004 · Trends in Pharmacological Sciences
Molecular Dynamics Simulation of Amyloid β Dimer Formation
Brigita Urbanc, Luis Cruz, Feng Ding, Deanne W. Sammond, Sagar D. Khare, Sergey V. Buldyrev, Eugene Stanley, Nikolay V. Dokholyan · 2004 · Biophysical Journal
Gleevec inhibits β-amyloid production but not Notch cleavage
William J. Netzer, Fei Dou, Dongming Cai, Darren R. Veach, Stéphanie Jean, Yue‐Ming Li, William G. Bornmann, Bayard Clarkson, Huaxi Xu, Paul Greengard · 2003 · Proceedings of the National Academy of Sciences
When loss is gain: reduced presenilin proteolytic function leads to increased Aβ42/Aβ40
Michael S. Wolfe · 2007 · EMBO Reports
Ferulic Acid Is a Nutraceutical β-Secretase Modulator That Improves Behavioral Impairment and Alzheimer-like Pathology in Transgenic Mice
Takashi Mori, Naoki Koyama, Marie‐Victoire Guillot‐Sestier, Jun Tan, Terrence Town · 2013 · PLoS ONE
Therapeutic strategies for Alzheimer's disease
Michael S. Wolfe · 2002 · Nature Reviews Drug Discovery
The Canine (Dog) Model of Human Aging and Disease: Dietary, Environmental and Immunotherapy Approaches
Carl W. Cotman, Elizabeth Head · 2008 · Journal of Alzheimer s Disease
Angiotensin-Converting Enzyme Converts Amyloid β-Protein 1–42 (Aβ1–42) to Aβ1–40, and Its Inhibition Enhances Brain Aβ Deposition
Kun Zou, H. Yamaguchi, H. Akatsu, Takaaki Sakamoto, Mihee Ko, K. Mizoguchi, J. Gong, Wenxin Yu, Takayuki Yamamoto, K. Kosaka et al. · 2007 · Journal of Neuroscience
Molecular Orbital Basis for Yellow Curry Spice Curcumin's Prevention of Alzheimer's Disease
K. Balasubramanian · 2006 · Journal of Agricultural and Food Chemistry
Differential Effects between γ-Secretase Inhibitors and Modulators on Cognitive Function in Amyloid Precursor Protein-Transgenic and Nontransgenic Mice
Mitani, Yasuyuki, Yarimizu, Junko, Saita, Kyoko, Uchino, Hiroshi, Akashiba, Hiroki, Shitaka, Yoshitsugu, Ni, Keni, Matsuoka, Nobuya · 2012 · The Journal of Neuroscience
Berberine alters the processing of Alzheimer’s amyloid precursor protein to decrease Aβ secretion
Masashi Asai, Nobuhisa Iwata, Ayumu Yoshikawa, Yoshimi Aizaki, Shoichi Ishiura, Takaomi C. Saido, Kei Maruyama · 2006 · Biochemical and Biophysical Research Communications
Transformation of Diffuse &bgr;-Amyloid Precursor Protein and &bgr;-Amyloid Deposits to Plaques in the Thalamus After Transient Occlusion of the Middle Cerebral Artery in Rats
T. van Groen, K. Puurunen, Hanna-Mari Mäki, J. Sivenius, J. Jolkkonen · 2005 · Stroke
Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease
Dionisio-Santos, Dawling A., Olschowka, John A., O’Banion, M. Kerry · 2019 · Journal of Neuroinflammation
Neuroinflammatory perspectives on the two faces of Alzheimer?s disease
Piet Eikelenboom, Willem A. van Gool · 2004 · Journal of Neural Transmission
Nonsteroidal Anti-Inflammatory Drugs Promote Axon Regeneration via RhoA Inhibition
Qiao Fu, Jeongsim Hue, Shuxin Li · 2007 · Journal of Neuroscience
Combination Therapy in Alzheimer???s Disease: A Review of Current Evidence
Schmitt, Beate, Bernhardt, Tanja, Moeller, Hans-Juergen, Heuser, Isabella, Fr??lich, Lutz · 2004 · CNS Drugs
Tannic Acid Is a Natural β-Secretase Inhibitor That Prevents Cognitive Impairment and Mitigates Alzheimer-like Pathology in Transgenic Mice
Takashi Mori, Kavon P. Rezai-Zadeh, Naoki Koyama, Gary W. Arendash, Haruyasu Yamaguchi, Nobuto Kakuda, Yuko Horikoshi‐Sakuraba, Jun Tan, Terrence Town · 2012 · Journal of Biological Chemistry
Sulindac Sulfide Is a Noncompetitive γ-Secretase Inhibitor That Preferentially Reduces Aβ42 Generation
Yasuko Takahashi, Ikuo Hayashi, Yusuke Tominari, Kentaro Rikimaru, Yuichi Morohashi, Toshiyuki Kan, Hideaki Natsugari, Tohru Fukuyama, Taisuke Tomita, Takeshi Iwatsubo · 2003 · Journal of Biological Chemistry
3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors Attenuate β-Amyloid-Induced Microglial Inflammatory Responses
Andrew C. Cordle, Gary E. Landreth · 2005 · Journal of Neuroscience
Mild cognitive impairment clinical trials
Ronald Carl Petersen · 2003 · Nature Reviews Drug Discovery
Microglia as a Potential Bridge between the Amyloid β‐Peptide and Tau
Masashi Kitazawa, Tritia R. Yamasaki, Frank M. LaFerla · 2004 · Annals of the New York Academy of Sciences